About On Demand Therapeutics
On Demand Therapeutics is a company based in Menlo Park (United States) founded in 2009 by Gil Kliman. It operates as a B2B. On Demand Therapeutics has raised $3.75 million across 3 funding rounds from investors including InterWest. On Demand Therapeutics operates in a competitive market with competitors including Eyenovia, Kedalion Thera, PolyActiva, iVeena Delivery Systems and Re-Vana Therapeutics, among others.
- Headquarter Menlo Park, United States
- Founders Gil Kliman
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.75 M (USD)
in 3 rounds
-
Latest Funding Round
$2.62 M (USD), Seed
Jun 17, 2011
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of On Demand Therapeutics
On Demand Therapeutics has successfully raised a total of $3.75M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.62 million completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $2.6M
-
First Round
First Round
(22 Jul 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2011 | Amount | Seed - On Demand Therapeutics | Valuation |
investors |
|
| May, 2010 | Amount | Seed - On Demand Therapeutics | Valuation | InterWest Partners |
|
| Jul, 2009 | Amount | Seed - On Demand Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in On Demand Therapeutics
On Demand Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include InterWest. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investing in IT and healthcare ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by On Demand Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - On Demand Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
On Demand Therapeutics Comparisons
Competitors of On Demand Therapeutics
On Demand Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eyenovia, Kedalion Thera, PolyActiva, iVeena Delivery Systems and Re-Vana Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microdose therapies for myopia treatment are developed with Optejet dispenser.
|
|
| domain | founded_year | HQ Location |
Provider of drug delivery system for eye diseases
|
|
| domain | founded_year | HQ Location |
A platform for slow-release, site-specific drug delivery is developed.
|
|
| domain | founded_year | HQ Location |
Ocular drug products for drop-free cataract surgery are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery platform for ophthalmic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Drug & a cell targeting system for posterior segment eye diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about On Demand Therapeutics
When was On Demand Therapeutics founded?
On Demand Therapeutics was founded in 2009.
Where is On Demand Therapeutics located?
On Demand Therapeutics is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is On Demand Therapeutics a funded company?
On Demand Therapeutics is a funded company, having raised a total of $3.75M across 3 funding rounds to date. The company's 1st funding round was a Seed of $830K, raised on Jul 22, 2009.
What does On Demand Therapeutics do?
On Demand Therapeutics develops laser-activated implants for targeted drug delivery through providing healthcare solutions, developing medical devices, drug delivery, and laser-activated implants. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of On Demand Therapeutics?
On Demand Therapeutics's top competitors include Eyenovia, PolyActiva and iVeena Delivery Systems.
Who are On Demand Therapeutics's investors?
On Demand Therapeutics has 1 investor. Key investors include InterWest.